Literature DB >> 15014008

Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer.

Sylke Schneider1, JiMin Yochim, Jan Brabender, Kazumi Uchida, Kathleen D Danenberg, Ralf Metzger, Paul M Schneider, Dennis Salonga, Arnulf H Hölscher, Peter V Danenberg.   

Abstract

PURPOSE: The purpose of this study was to better define the role of osteopontin (OPN) and osteonectin [also known as secreted protein acidic and rich in cysteine (SPARC)] in lung tumorigenesis by comparing the expressions of these genes in lung tumor tissue and matched normal tissue and by determining the prognostic significance of the gene expressions. EXPERIMENTAL
DESIGN: Quantitative real-time reverse transcription-PCR was used to analyze OPN and SPARC mRNA expression in normal lung tissue and matching tumor samples from 82 patients with non-small cell lung cancer. Gene expression data for each patient were matched to survival data.
RESULTS: The overall median mRNA expression level of OPN was about 20-fold higher in tumor tissues than in matching normal lung tissues (P < 0.001), whereas SPARC gene expression was not significantly different in both tissue types. Forty of 82 patients had high (>or=4.1) intratumoral OPN expression, and 15 of 82 patients had high (>or15.5) SPARC expression. High OPN expression in the tumor tissue was associated with inferior survival (P = 0.014), whereas high SPARC expression showed a trend toward longer survival (P = 0.095). The impact of high OPN and low SPARC expression on patient survival was additive (P = 0.001).
CONCLUSIONS: The large increase in OPN expression in tumors compared with normal tissue and its association with survival suggest a role for OPN in lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014008     DOI: 10.1158/1078-0432.ccr-0565-3

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  26 in total

Review 1.  Prognostic significance of osteopontin in patients with lung cancer: a meta-analysis.

Authors:  Bin Peng; Yi-Han Wang; Zhuo Huang; Shi-Jian Feng; Yong-Sheng Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye.

Authors:  Uttio Roy Chowdhury; Seung-Youn Jea; Dong-Jin Oh; Douglas J Rhee; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-16       Impact factor: 4.799

3.  Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis.

Authors:  Xue-Lin Zou; Chun Wang; K E Liu; Wen Nie; Zhen-Yu Ding
Journal:  Mol Clin Oncol       Date:  2015-02-26

4.  Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma.

Authors:  Amy L Collins; Jonathan Rock; Lavina Malhotra; Wendy L Frankel; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2012-03-30       Impact factor: 5.344

Review 5.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

6.  The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis.

Authors:  Tao Zhang; Dong-Ming Zhang; Da Zhao; Xiao-Ming Hou; Xiao-Jun Liu; Xiao-Ling Ling; Shou-Cheng Ma
Journal:  J Mol Histol       Date:  2014-05-10       Impact factor: 2.611

7.  Comparison of osteopontin, beta-catenin and hnRNP B1 expression in lung carcinomas.

Authors:  Muhammet Emin Guldur; Yasemin Kibar; Hale Deniz; Kemal Bakir
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

8.  Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.

Authors:  Matthias Bache; Matthias Kappler; Henri Wichmann; Swetlana Rot; Antje Hahnel; Thomas Greither; Harun M Said; Matthias Kotzsch; Peter Würl; Helge Taubert; Dirk Vordermark
Journal:  BMC Cancer       Date:  2010-04-08       Impact factor: 4.430

9.  Osteopontin expression in squamous cell cancer of the esophagus.

Authors:  I-Chen Wu; Ming-Tsang Wu; Shah-Hwa Chou; Sheau-Fang Yang; Yih-Gang Goan; Jang-Ming Lee; Yi-Pin Chou; Ming-Jong Bair; Tsang-En Wang; Angela Chen; Wen-Hsiung Chang; Fu-Chen Kuo; Deng-Chyang Wu
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

10.  A white-box approach to microarray probe response characterization: the BaFL pipeline.

Authors:  Kevin J Thompson; Hrishikesh Deshmukh; Jeffrey L Solka; Jennifer W Weller
Journal:  BMC Bioinformatics       Date:  2009-12-29       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.